Clinically significant vitamin B 12 deficiency and megaloblastic anemia are unlikely, unless these drug therapies are prolonged for two or more years, or if in addition, the person's dietary intake is below recommended levels
The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies
ISSN 2072-6643
Patients report faster pigmentation correction, more even tone, and a general quality that they describe as their skin looking more like it did years earlier
Serum peak is faster than IM, and B12 can be combined with hydration (saline), B-complex, vitamin C, magnesium, and other ingredients in the same bag